What are Catalyst Pharmaceutical's profit margins?

Catalyst Pharmaceutical (CPRX) runs a 86.0% gross margin and a 44.8% operating margin, with a 37.1% net margin.

Where do Catalyst Pharmaceutical's ratios come from?

Every ratio is computed from Catalyst Pharmaceutical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Catalyst Pharmaceutical CPRX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	86%-0.2pp	85.2%-0.8pp	85.7%-0.6pp	85.8%-0.9pp	86.1%-0.6pp
Operating margin	44.8%+1.6pp	43.8%+4.1pp	44.8%+7.0pp	43.6%+23.8pp	43.3%+24.2pp
Net margin	37.1%+0.2pp	36.4%+3.1pp	37.6%+6.6pp	37.4%+21.7pp	36.9%+21.1pp
EBITDA margin	51.2%+0.9pp	50.2%+2.8pp	51.3%+5.4pp	50.4%+22.2pp	50.3%+22.6pp
Free cash flow margin	34.9%-15.2pp	35.4%-13.2pp	40.6%-8.1pp	49.2%+4.0pp	50%+10.4pp
Returns
Return on equity	24.5%-4.6pp	25.5%-3.9pp	27.5%-0.8pp	28.5%+14.6pp	29.1%+14.6pp
Return on assets	21.5%-3.8pp	21.9%-2.9pp	23.9%-0.2pp	24.9%+13.0pp	25.4%+13.0pp
Return on invested capital	83.9%+8.9pp	84.5%+21.2pp	86.6%+28.5pp	84.4%+55.7pp	75%+48.3pp
Efficiency
Asset turnover	0.6×-0.1×	0.6×-0.1×	0.6×-0.1×	0.7×-0.1×	0.7×-0.1×
Inventory turnover	3.1×-0.7×	3.1×-0.8×	3.4×-0.9×	4.3×+0.3×	3.7×+0.1×
Liquidity
Current ratio	7.1×+1.0×	6.1×+0.9×	6.6×+1.5×	6.7×+1.6×	6.1×+1.1×
Quick ratio	6.8×+0.9×	5.8×+0.8×	6.4×+1.5×	6.5×+1.6×	6×+1.1×
Cash ratio	5.7×+0.5×	4.8×+0.5×	5.4×+1.2×	5.8×+1.7×	5.2×+1.3×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	-2.5×-0.3×	-2.4×-0.2×	-2.3×-0.2×	-2.3×+0.7×	-2.1×+0.5×
Per Share
Book value per share	$7.98+27.6%	$7.50+28.8%	$7.24+37.4%	$6.71+37.5%	$6.26+37.5%
Valuation
Market capitalization	$3.02B+2.7%	$2.87B+15.2%	$2.41B+2.2%	$2.69B+47.1%	$2.95B+56.8%
Enterprise value	$2.27B-4.1%	$2.16B+9.5%	$1.72B-10.2%	$2.04B+40.1%	$2.37B+50.6%
Price / earnings	13.7×-1.3×	13.4×-1.8×	11.1×-5.4×	12.9×-13.9×	14.9×-13.9×
Price / sales	5.1×-0.4×	4.9×-0.2×	4.2×-1.0×	4.8×+0.6×	5.5×+0.9×
Price / book	3×-0.7×	3×-0.4×	2.6×-0.9×	3.1×+0.1×	3.7×+0.4×
EV / EBITDA	7.4×-1.4×	7.3×-1.2×	5.8×-3.3×	7.3×-4.6×	8.8×-5.0×
EV / sales	3.8×-0.6×	3.7×-0.3×	3×-1.2×	3.7×+0.3×	4.4×+0.6×
Free cash flow yield	6.9%-2.2pp	7.3%-2.3pp	9.7%+0.2pp	10.2%-0.5pp	9.1%+0.4pp
Earnings yield	7.3%+0.6pp	7.5%+0.9pp	9%+3.0pp	7.8%+4.0pp	6.7%+3.2pp
PEG ratio	1.1×+1.1×	0.4×+0.3×	0.2×+0.1×	0.1×—	0.1×—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Catalyst Pharmaceutical.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Catalyst Pharmaceutical's profit margins?: Catalyst Pharmaceutical (CPRX) runs a 86.0% gross margin and a 44.8% operating margin, with a 37.1% net margin.
Where do Catalyst Pharmaceutical's ratios come from?: Every ratio is computed from Catalyst Pharmaceutical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.